AIM Vaccine (06660.HK), a leading domestic vaccine company, announced on January 15 that its research and development of the iterative process high-efficiency diploid rabies vaccine has successfully ...

Partnership brings Iterative Health’s artificial intelligence technology to patients across the Florida region CAMBRIDGE, Mass.--(BUSINESS WIRE)--Iterative Health, a pioneer in precision-medicine ...